Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Journey Medical stock

DERM
US48115J1097

Price

6.29
Today +/-
+0.02
Today %
+0.32 %
P

Journey Medical stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Journey Medical stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Journey Medical stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Journey Medical stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Journey Medical's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Journey Medical Stock Price History

DateJourney Medical Price
10/3/20246.29 undefined
10/2/20246.27 undefined
10/1/20245.81 undefined
9/30/20245.65 undefined
9/27/20245.72 undefined
9/26/20245.47 undefined
9/25/20245.42 undefined
9/24/20245.20 undefined
9/23/20245.16 undefined
9/20/20245.05 undefined
9/19/20245.08 undefined
9/18/20245.12 undefined
9/17/20245.05 undefined
9/16/20245.43 undefined
9/13/20245.16 undefined
9/12/20245.01 undefined
9/11/20244.79 undefined
9/10/20244.76 undefined
9/9/20244.83 undefined
9/6/20244.68 undefined
9/5/20244.70 undefined

Journey Medical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Journey Medical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Journey Medical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Journey Medical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Journey Medical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Journey Medical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Journey Medical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Journey Medical’s growth potential.

Journey Medical Revenue, EBIT and net profit per share

DateJourney Medical RevenueJourney Medical EBITJourney Medical Net Income
2026e81.2 M undefined-4.42 M undefined-6.31 M undefined
2025e87.7 M undefined-13.51 M undefined-300,492 undefined
2024e58.24 M undefined-17.86 M undefined-14.72 M undefined
202379.18 M undefined1.07 M undefined-3.85 M undefined
202273.67 M undefined-27.52 M undefined-29.63 M undefined
202163.13 M undefined-34.88 M undefined-43.99 M undefined
202044.53 M undefined7.85 M undefined5.28 M undefined
201934.92 M undefined5.26 M undefined3.63 M undefined

Journey Medical Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
201920202021202220232024e2025e2026e
3444637379588781
-29.4143.1815.878.22-26.5850.00-6.90
70.5965.9149.2157.5365.82---
2429314252000
57-34-271-17-13-4
14.7115.91-53.97-36.991.27-29.31-14.94-4.94
35-43-29-3-140-6
-66.67-960.00-32.56-89.66366.67--
16.4416.4410.1917.5318.23000
--------
Details

Keystats

ⓘ

Revenue and Growth

The Journey Medical Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Journey Medical is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (k)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20192020202120222023
         
4.88.249.13227.44
1923.923.128.215.22
00000
0.91.49.914.210.21
0.71.72.43.33.59
25.435.284.577.756.46
100200100200101
00000
00000
7.41512.627.220.29
00000
1.11.50.20.10.01
8.616.712.927.520.39
3451.997.4105.276.85
         
00002
2.95.280.985.592.7
-0.25.1-38.9-68.5-72.36
00000
00000
2.710.3421720.35
2.1223.43718.34
18.821.622.919.620.47
00050.05
00000
04.55.35.23
20.928.151.666.841.87
10.213.43.621.214.62
00000
020001009
10.213.63.621.314.63
31.141.755.288.156.5
33.85297.2105.176.85
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Journey Medical provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Journey Medical's financial health and stability.

Assets

Journey Medical's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Journey Medical must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Journey Medical after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Journey Medical's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (k)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2019202020212022
35-43-29
1124
001,0000
3-2146
012510
0000
0000
95-2-13
-2-1-10-20
-2-1-10-20
0000
0000
-30516
00510
-305316
---3.00-
0000
3340-17
6.623.93-12.18-33.53
0000

Journey Medical stock margins

The Journey Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Journey Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Journey Medical.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Journey Medical's sales revenue. A higher gross margin percentage indicates that the Journey Medical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Journey Medical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Journey Medical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Journey Medical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Journey Medical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Journey Medical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Journey Medical Margin History

Journey Medical Gross marginJourney Medical Profit marginJourney Medical EBIT marginJourney Medical Profit margin
2026e66.33 %-5.45 %-7.77 %
2025e66.33 %-15.41 %-0.34 %
2024e66.33 %-30.66 %-25.28 %
202366.33 %1.35 %-4.87 %
202258.22 %-37.36 %-40.22 %
202149.18 %-55.25 %-69.68 %
202067.24 %17.63 %11.86 %
201969.85 %15.06 %10.4 %

Journey Medical Stock Sales Revenue, EBIT, Earnings per Share

The Journey Medical earnings per share therefore indicates how much revenue Journey Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Journey Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Journey Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Journey Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Journey Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Journey Medical Revenue, EBIT and net profit per share

DateJourney Medical Sales per ShareJourney Medical EBIT per shareJourney Medical Earnings per Share
2026e5.51 undefined0 undefined-0.43 undefined
2025e5.95 undefined0 undefined-0.02 undefined
2024e3.95 undefined0 undefined-1 undefined
20234.34 undefined0.06 undefined-0.21 undefined
20224.2 undefined-1.57 undefined-1.69 undefined
20216.2 undefined-3.42 undefined-4.32 undefined
20202.71 undefined0.48 undefined0.32 undefined
20192.12 undefined0.32 undefined0.22 undefined

Journey Medical business model

Journey Medical Corp is a US-American company specializing in the development and marketing of medical products and services. It was founded in 2018 by healthcare veterans with over 20 years of experience in the industry. The company's business model focuses on providing high-quality and innovative medications and diagnostic products. It specializes in developing treatment options in the fields of dermatology, gynecology, urology, and podiatry. Journey Medical Corp offers products such as Sorilux for the treatment of psoriasis vulgaris in adults, Tumor Treating Fields for various types of salivary and laryngeal cancer, Vyleesi for women with sexual dysfunction, CaroSpir for hypertension treatment, and a range of dermatological products for skincare. The company has a strong customer base consisting of dermatologists, gynecologists, urologists, podiatrists, and other healthcare professionals. It has over 80 employees in the USA and Europe, with headquarters in Scottsdale, Arizona, and offices in New York, San Francisco, and London. Journey Medical Corp is committed to research and development and aims to expand its product range and venture into new areas of medicine to provide innovative and effective solutions for its customers and the medical community. Journey Medical is one of the most popular companies on Eulerpool.com.

Journey Medical SWOT Analysis

Strengths

Journey Medical Corp has a strong market presence and brand recognition in the medical industry.

The company possesses a diverse product portfolio, offering a wide range of medical solutions.

Journey Medical Corp has a robust distribution network, allowing for efficient product delivery.

The company benefits from a highly skilled and experienced management team.

Weaknesses

Journey Medical Corp may face challenges in adapting to rapidly changing market trends.

The company's heavy reliance on a few key suppliers could lead to supply chain vulnerabilities.

Journey Medical Corp might have limited financial resources for significant research and development initiatives.

Opportunities

The growing demand for medical products presents an opportunity for Journey Medical Corp to expand its market share.

Advancements in technology offer the potential for innovative medical solutions and treatments.

Journey Medical Corp can explore strategic partnerships to enhance its product offerings and enter new markets.

Threats

Intense market competition could erode Journey Medical Corp's market share and profitability.

Regulatory changes and compliance requirements may pose challenges for the company.

Economic instability or recessions could impact consumer spending on medical products.

Journey Medical Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Journey Medical historical P/E ratio, EBIT multiple, and P/S ratio

Journey Medical shares outstanding

The number of shares was Journey Medical in 2023 — This indicates how many shares 18.232 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Journey Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Journey Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Journey Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Journey Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Journey Medical.

Journey Medical latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.15 -0.17  (-16.28 %)2024 Q2
3/31/2024-0.24 -0.53  (-121.11 %)2024 Q1
12/31/2023-0.08 -0.12  (-53.45 %)2023 Q4
9/30/2023-0.16 0.8  (606.01 %)2023 Q3
6/30/2023-0.34 -0.29  (15.13 %)2023 Q2
3/31/2023-0.46 -0.57  (-25.11 %)2023 Q1
12/31/2022-0.48 -0.6  (-26.05 %)2022 Q4
9/30/2022-0.4 -0.57  (-40.88 %)2022 Q3
6/30/2022-0.26 -0.43  (-64.25 %)2022 Q2
3/31/2022-0.32 -0.08  (74.7 %)2022 Q1
1
2

Journey Medical shareholders

%
Name
Stocks
Change
Date
22.98348 % Fortress Biotech Inc3,385,467-225,0004/25/2023
2.16064 % Maraoui (Claude)318,26210,0003/22/2024
2.08058 % Rosenwald (Lindsay A)306,47030,0003/25/2024
1.77189 % Renaissance Technologies LLC261,000240,10012/31/2023
1.76447 % De Paolantonio (Ernest Robert)259,907-10,09310/4/2022
1.22200 % American Financial Group, Inc.180,000012/31/2023
0.91458 % Smith (Justin Adam)134,71730,0003/22/2024
0.87881 % The Vanguard Group, Inc.129,44856,78112/31/2023
0.75023 % EAM Investors, LLC110,509110,50912/31/2023
0.64141 % Neuberger Berman, LLC94,479-16,07512/31/2023
1
2
3
4
5
...
7

Journey Medical Executives and Management Board

Mr. Claude Maraoui56
Journey Medical President, Chief Executive Officer, Director (since 2021)
Compensation 1.87 M
Mr. Neil Herskowitz65
Journey Medical Independent Director
Compensation 263,300
Mr. Justin Smith48
Journey Medical Independent Director
Compensation 253,300
Ms. Miranda Toledano45
Journey Medical Independent Director
Compensation 253,300
Dr. Lindsay Rosenwald67
Journey Medical Executive Chairman of the Board (since 2014)
Compensation 100,000
1
2

Most common questions regarding Journey Medical

What values and corporate philosophy does Journey Medical represent?

Journey Medical Corp represents a strong commitment to patient care, innovation, and quality in the field of dermatology and medical aesthetics. With a focus on providing advanced solutions for various skin conditions and aesthetic concerns, the company aims to improve the overall well-being and confidence of individuals. Journey Medical Corp thrives on a philosophy of evidence-based medicine, utilizing cutting-edge research and technologies to deliver effective and safe treatments. By prioritizing patient satisfaction and welfare, Journey Medical Corp continually strives to set new standards in the industry, making significant contributions to the advancement of dermatological healthcare.

In which countries and regions is Journey Medical primarily present?

Journey Medical Corp is primarily present in the United States.

What significant milestones has the company Journey Medical achieved?

Journey Medical Corp has achieved several significant milestones since its establishment. The company has successfully developed and launched various innovative dermatological products, contributing to its growth and reputation. In addition, Journey Medical Corp has successfully garnered several strategic partnerships and collaborations with well-known medical institutions and professionals. The company's commitment to research and development has resulted in the introduction of cutting-edge treatments and therapies, enhancing patient care and outcomes. Furthermore, Journey Medical Corp has demonstrated consistent financial growth and profitability, showcasing its ability to thrive in the competitive healthcare market. These milestones highlight Journey Medical Corp's dedication to advancing dermatological solutions and establishing its position as a leading player in the industry.

What is the history and background of the company Journey Medical?

Journey Medical Corp is a leading pharmaceutical company specializing in dermatology treatments. Established in [year], the company has rapidly grown to become a trusted name in the industry. Journey Medical Corp focuses on developing innovative solutions for various skin conditions, aiming to improve the lives of patients worldwide. With a strong commitment to research and development, the company has consistently introduced groundbreaking therapies, drawing upon a team of experienced professionals and cutting-edge technology. Journey Medical Corp's dedication to exceptional quality and patient care has solidified its position as a market leader, garnering recognition and trust from both healthcare professionals and consumers alike.

Who are the main competitors of Journey Medical in the market?

The main competitors of Journey Medical Corp in the market include companies like Pfizer, Johnson & Johnson, Novartis, and GlaxoSmithKline.

In which industries is Journey Medical primarily active?

Journey Medical Corp is primarily active in the healthcare and pharmaceutical industries.

What is the business model of Journey Medical?

The business model of Journey Medical Corp is centered around developing and commercializing innovative therapeutics to address dermatological conditions and unmet medical needs. Journey Medical Corp focuses on acquiring and advancing late-stage or marketed specialty pharmaceutical products through its proven sales and marketing capabilities. By strategically targeting a diverse range of skin-related conditions, the company aims to provide effective solutions and improve patients' quality of life. Journey Medical Corp's commitment to research, development, and commercialization makes it a trusted provider of advanced dermatological treatments.

What is the P/E ratio of Journey Medical 2024?

The Journey Medical P/E ratio is -7.79.

What is the P/S ratio of Journey Medical 2024?

The Journey Medical P/S ratio is 1.97.

What is the AlleAktien quality score of Journey Medical?

The AlleAktien quality score for Journey Medical is 2/10.

What is the revenue of Journey Medical 2024?

The expected Journey Medical revenue is 58.24 M USD.

How high is the profit of Journey Medical 2024?

The expected Journey Medical profit is -14.72 M USD.

What is the business model of Journey Medical

Journey Medical Corp is a United States-based company specializing in the development and marketing of medical products and services. They are active in various segments and offer a wide range of products and solutions.

What is the Journey Medical dividend?

Journey Medical pays a dividend of 0 USD distributed over payouts per year.

How often does Journey Medical pay dividends?

The dividend cannot currently be calculated for Journey Medical or the company does not pay out a dividend.

What is the Journey Medical ISIN?

The ISIN of Journey Medical is US48115J1097.

What is the Journey Medical ticker?

The ticker of Journey Medical is DERM.

How much dividend does Journey Medical pay?

Over the past 12 months, Journey Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Journey Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Journey Medical?

The current dividend yield of Journey Medical is .

When does Journey Medical pay dividends?

Journey Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Journey Medical?

Journey Medical paid dividends every year for the past 0 years.

What is the dividend of Journey Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Journey Medical located?

Journey Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Journey Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Journey Medical from 10/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.

When did Journey Medical pay the last dividend?

The last dividend was paid out on 10/4/2024.

What was the dividend of Journey Medical in the year 2023?

In the year 2023, Journey Medical distributed 0 USD as dividends.

In which currency does Journey Medical pay out the dividend?

The dividends of Journey Medical are distributed in USD.

All fundamentals about Journey Medical

Our stock analysis for Journey Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Journey Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.